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Abstract 
 
Complex I has an essential role in ATP production by coupling electron transfer from 
NADH to quinone with translocation of protons across the inner mitochondrial 
membrane. Isolated complex I deficiency is a frequent cause of mitochondrial inherited 
diseases. Complex I has also been implicated in cancer, ageing and neurodegenerative 
conditions. Until recently, the understanding of complex I deficiency on the molecular 
level was limited due to the lack of high-resolution structures of the enzyme. However, 
due to developments in single particle cryo-electron microscopy, recent studies have 
reported nearly atomic resolution maps and models of mitochondrial complex I. These 
structures significantly add to our understanding of complex I mechanism and 
assembly. The disease-causing mutations are discussed herein their structural context.  
 
Mitochondrial Disease and Complex I Deficiency 
The mitochondrial respiratory chain is responsible for converting energy produced 
during metabolism into ATP. Electrons harvested from the catabolic processes in the 
form of NADH enter the chain via the proton-pumping NADH-ubiquinone 
oxidoreductase (complex I or CI), the largest and the most elaborate component of the 
chain. These electrons are then passed via ubiquinone (hydrophobic electron carrier) to 
the proton-pumping ubiquinone-cytochrome c oxidoreductase (complex III, existing as 
a functional dimer CIII2) and, finally via cytochrome c to the proton-pumping 
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cytochrome c oxidase (complex IV or CIV), which catalyzes the reduction of molecular 
oxygen to water [1]. These complexes transport protons out of the mitochondrial matrix, 
generating the electrochemical proton gradient across the inner membrane, used by ATP 
synthase (complex V) to synthesize ATP [2]. About 30% of mitochondrial diseases 
affecting energy metabolism can be traced to mutations in the nuclear or mitochondrial 
DNA encoding the subunits of mitochondrial complex I [3]. On the molecular level, all 
of the diseases are characterized by defects in oxidative phosphorylation, but patients’ 
symptoms vary widely in nature and severity. Unfortunately, general prognoses are 
poor. About 50% of patients diagnosed with complex I deficiency die within the first 
two years of life and only 25% reach the age of ten [4]. The first signs are usually 
observed shortly after birth and affect the central nervous system. The most common 
clinical presentations are Leber’s hereditary optic neuropathy (LHON), infantile-onset 
Leigh syndrome, fatal neonatal lactic acidosis, childhood-onset mitochondrial 
encephalomyopathy and lactic acidosis and stroke-like episodes syndrome (MELAS) 
[5] (Table 1). 
 
A general genotype-phenotype correlation has not been clearly established so far [6]. It 
is not well understood how mutations in certain complex I related genes translate to 
specific clinical phenotypes. An often-cited example of this ambiguity is a mutation in 
position Arg340 of the ND4 subunit. Substitution to histidine causes LHON syndrome 
[7] but that to serine results in Leigh syndrome [8] (Table 1).  
 
Additionally, prediction of clinical features based on sequencing data is limited due to 
the fact that patients are often heterozygotes or display various levels of mitochondrial 
heteroplasmy in different tissues [9] [10]. Thus, clinical representation of complex I 
deficiency is an outcome of translation from a number of different ‘natural’ variants and 
corrupted gene alleles. Resulting haploinsufficiency can lead to improper complex I 
assembly or insufficient respiration levels (Table 1). Furthermore, there are at least 15 
assembly factors known to be required for the complete maturation of complex I 
[11,12]. Mutations in most of them can also cause complex I deficiency and associated 
mitochondrial disease [11]. 
 
A better understanding of complex I dysfunction caused by mutations has been 
obstructed by the lack of high-resolution models for mitochondrial complex I. Until 
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recently most of the data regarding the atomic structure of the complex was obtained 
from X-ray crystallography models of bacterial enzymes [13-15]. In general, bacterial 
complex I consists of 14 “core” protein subunits found in two main domains: seven 
hydrophilic subunits form the peripheral arm (or matrix arm in mitochondrial enzyme) 
and seven hydrophobic subunits form the membrane arm. In each catalytic cycle, the 
transfer of two electrons from NADH to ubiquinone (Q) is tightly coupled to the 
translocation of four protons across the membrane [16]. These processes are spatially 
separated. Electron transfer takes place in the matrix arm, which contains all the redox 
cofactors, including primary electron acceptor FMN, connected via seven FeS clusters 
to the Q binding site at the interface with the membrane arm (Figure 1 and Box 1). The 
energy released in this redox reaction drives proton translocation in the membrane arm, 
containing four putative proton channels [15]. The core is highly conserved from 
bacteria to humans and forms a functional foundation of the more elaborate, containing 
many additional subunits, mitochondrial enzyme (Figure 1) [17,18]. Bacterial structures 
thus provide a good model to understand the general principles of complex I function; 
however, the role of 31 accessory or “supernumerary” subunits in the mitochondrial 
enzyme, increasing its total molecular weight from ~ 550 to ~ 980 kDa, remained 
enigmatic. In eukaryotes, all seven hydrophobic core subunits of complex I are encoded 
in the mitochondrial DNA (NDx subunits), while seven hydrophilic core subunits and 
all supernumerary subunits are nuclear-encoded (NDUFx subunits). A first crystal 
structure of the mitochondrial enzyme was determined at 3.8 Å resolution using enzyme 
from aerobic yeast Yarrowia lipolytica, providing partial atomic models of core 
subunits while supernumerary subunits were mostly unidentified and modelled as poly-
alanine [19]. In 2016, thanks to developments in cryo-electron microscopy (cryo-EM) 
technology, several models of mammalian complex I from different species were 
published [20-23].  
 
Here we will compare these structures and discuss briefly how they add to our 
understanding of complex I mechanism and function. We then review disease-causing 
single amino acid substitutions in the enzyme. Throughout the review, we will use 
human nomenclature for the complex I subunits with bovine names in parentheses. 
Residue numbers are according to sequence numbers of the open reading frame of the 
gene (i.e. including mitochondrial targeting sequence) as is traditional in the medical 
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literature, although Table 1 also includes residue numbers in the mature (mitochondria-
targeting sequence cleaved) nuclear-encoded subunits as present in the structures. 
 
Comparison of recently published models. 
 
In 2016, a partial model (65% atomic for core subunits and 27% atomic for 
supernumerary subunits) for bovine [20] and nearly complete (88% atomic) ovine [21] 
and (84% atomic) porcine [22] models of mitochondrial complex I became available at 
4.3Å, 3.9Å and 3.6Å resolution respectively. The subunit composition of these enzymes 
is identical to human, with about 85% average sequence identity [24], therefore they 
represent very good models for human complex I as well. In mammalian mitochondria 
the respiratory chain is organized mostly into supercomplexes or “respirasomes” and CI 
exists mainly as part of a larger assembly along with CIII2 and CIV [25,26]. The 
porcine CI structure was solved using supercomplex CI+CIII2+CIV and unfortunately, 
suffers from several flaws. Although maps from focused refinement of the matrix and 
membrane arms individually are of good quality, the map of the entire complex is 
blurry around the matrix arm. Most EM maps describing the intermediate states of 
processing are of the wrong hand (mirror image) in all three supercomplex publications 
from this group [22,23,27]. This can happen with the first dataset if the de novo starting 
model is generated and used until the hand is flipped in the final rounds of processing. 
However, why this happened again in two subsequent studies, when the starting 
supercomplex model should have been available, is not clear. Furthermore, the porcine 
complex I structure is described as being completely novel, even though the paper [22] 
was submitted nearly a month after the ovine structure was published [21]. In the 
deposited porcine model (PDB 5GUP) the B-factors are not refined, the iron-sulphur 
cluster geometry and environment are incorrect (e.g. 4Fe-4S clusters are ideal cubes 
instead of known distorted cubane shape with non-planar rhombic faces and Td 
symmetry, while Fe atoms are not linked to coordinating residues), the flavin 
mononucleotide (FMN) isoalloxazine ring is flipped, the non-existing (cleaved) 
mitochondrial targeting sequence of 24 kDa subunit is built into 10 kDa subunit density, 
sequence assignment to density in some areas is wrong and model statistics were not 
reported, among other problems. More recently, the structure of the human respiratory 
supercomplex, including complex I, was published by the same group [23]. Again, even 
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though the focused maps are of good quality, the work suffers from the similar 
problems as listed above. Also, in some areas the ovine complex I model is more 
consistent with the experimental cryo-EM density for human protein than the deposited 
human model. Therefore we use the ovine model (as it is higher resolution and more 
complete than the bovine model, except for the NDUFA11/B14.7 subunit, which is 
better resolved in the bovine study) as a reference model here. It was used as a basis for 
the homology model of the human enzyme, which was built in SWISSMODEL [28] 
using PDB 5LNK, followed by energy minimization in PHENIX [29].  
 
As expected from the sequence comparisons [24] all the models are very similar on the 
level of tertiary structure. However, on the level of quaternary structure, changes in the 
position of the peripheral arm (PA) relative to the membrane domain (MD) can be 
observed (Figure 2). It is also evident that previously discussed modules of the enzyme 
[18]: N-module (NADH-oxidising part of the peripheral arm, formed around subunits 
NDUFS1, NDUFV1 and NDUFV2), Q-module (the rest of the peripheral arm, 
connecting N-module with MD and containing most of the quinone-binding site) and 
the distal (Pd, formed around subunits ND4 and ND5) or proximal (Pp, the rest of MD) 
parts of the membrane domain (Figure 1) can move roughly as individual rigid bodies. 
 
Interestingly, comparison of models reveals a link between the positions of the PA 
relative to the MD and conformation of the catalytically important β1-β2NDUFS2(49kDa) 
loop (Figure 2F). The bovine and porcine models have both arms closer (the angle 
between the arms is smaller) and their PAs are rotationally closer to each other than the 
ovine model (Figure 2A-E). This position correlates with the β1-β2NDUFS2(49kDa) loop 
being retracted from the cavity, which would allow for Q reduction. In the ovine model, 
the PA and MD are more distant from each other and the loop is inserted, blocking the 
Q site (Figure 2F, blue). This change is accompanied by a different arrangement of the 
nearby α5-α6ND1 loop and the α1-α2ND3 loop, known to be crucial [30] for the active/de-
active (A/D) transition first observed many years ago [31]. 
 
It is possible that these different quaternary structures correspond to the A/D 
conformations [32-34] or to different catalytic states of the molecule, hinting at possible 
intermediates in the putative conformational coupling mechanism proposed by us (Box 
1). This is essentially a “one-stroke” per catalytic cycle model. Alternative proposals 
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include a “two-strokes” model whereby two events of stabilisation of anionic 
ubisemiquinone and ubiquinol are coupled to two sets of conformational changes each 
leading to translocation of two protons, resulting in four protons per cycle [19]. Another 
proposal is the electrostatically driven “wave-spring” model, whereby the cascade of 
electrostatic interactions spreads along the membrane domain of complex I, leading to 
alternating protonation and deprotonation of key lysines in antiporter-like subunits, 
resulting in proton translocation across the membrane [35]. The exact nature of the 
mechanism remains the hot topic for future investigations. 
 
Complex I deficiency-causing mutations. 
 
In patients suffering from complex I deficiency, mutations have been found in all of the 
core subunits and in most of the accessory subunits [36]. Changes in the sequence of the 
core subunits may alter the catalytic mechanism of the enzyme. Accessory subunits are 
not regarded to be directly involved in catalysis but it has been shown that most of them 
are indispensable for complex I maturation [37]. This is why mutations in the 
supernumerary subunits are more likely to cause complex disassembly. 
 
In addition maturation of complex I is also heavily dependent on different assembly 
factors. They are mostly associated with defined structural modules of the enzyme, such 
as N-, Q-, Pd and Pp-modules, and mutations in or deletions of these factors cause 
accumulation of corresponding sub-complexes [11]. Some of the assembly factors are 
homologous to structural subunits of complex I and serve as their “place holders” in 
assembly intermediates (e.g. NDUFAF2, a homologue of the NDUFA12 subunit [37]), 
while others are involved in post-translational modifications (e.g. NDUFAF5, an 
arginine hydroxylase of Arg73 in NDUFS7 [38], or NDUFAF7, required for 
dimethylation of Arg85 in NDUFS2 [39]). Factors helping in the folding of MD 
subunits often contain TM helices themselves (e.g. TIMMDC1, TMEM126B, TMEM70 
[40]). Therefore, it is not surprising that many known mutations in assembly factors are 
associated with human disease [11,12].  
 
In general, human diseases are caused by a wide range of often heterozygous mutations 
in nuclear DNA or by displaying various levels of mitochondrial heteroplasmy in 
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different tissues. The mutations can involve either structural subunits of complex I or its 
assembly factors, and include substitutions, insertions, deletions, inversions, 
duplications etc. leading to no or pre-maturely terminated protein translation. In this 
review, we will focus only on single amino acid mutations in structural subunits of 
complex I identified in complex I deficiency patients (Table 1). Information about 
disease-causing substitutions and corresponding phenotypes was acquired from HGDM, 
ClinVar and Mitomap databases. Results of extensive modelling by many research 
groups of some of these mutations, involving core subunits, in bacteria or lower 
eukaryotes, were summarised in our previous publications [14,15,41] and reviewed by 
others [35,42-45]. 
 
Interestingly, most of the LHON-linked mutations map to the membrane domain, while 
Leigh syndrome and other diseases are mostly caused by mutations in the peripheral 
arm (Figure 3). This could be related to a potential link between defects in the proton 
pumping apparatus and LHON-like phenotype.  
 
 
Core Subunits of the Peripheral (Matrix) Arm 
 
NDUFS1 (75kDa) subunit  
The reported mutations Val71Asp, Gly166Glu, Val228Ala, Leu231Val, Arg241Trp are 
located in close proximity to Fe-S clusters (Figure 4A). They form part of the loops 
crucial for the proper binding and stability of the clusters. For example, Val71 is located 
in the proximity of the N3 and N1b clusters in a loop interacting directly with cluster-
coordinating side chains.  
Other mutations Asp252Gly, Arg408Cys, Gln522Lys, Thr595Ala, Asp619Asn, 
Tyr695His/Cys and Met707Val are located in regions important for complex assembly 
(Table 1).  
 
NDUFV1 (51kDa) subunit  
The NDUFV1 subunit coordinates FMN, the primary electron acceptor [13]. Many 
mutations are located around the FMN binding site where NADH is oxidized and 
electron transfer starts Arg88Gly, Tyr204Cys, Cys206Gly, Ala211Val. Others, 
Pro122Leu, Glu214Lys, Arg386Cys, Thr423Met, Ala422Pro affect Fe-S cluster 
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binding, while Ser56Pro, Lys111Glu, Arg147Trp, Arg199Pro, Ala341Val are likely to 
affect the stability of the whole NADH oxidizing module (Figure 4B). Mutations that 
are not placed close to the catalytically important centres of the subunit and are more 
likely to affect assembly or perhaps FMN binding and Fe-S cluster stability in a more 
indirect way are Ser56Pro, Arg199Pro, Pro252Arg and Ala341Val.  
 
NDUFS2 (49kDa) subunit  
The Arg118Gln, Arg138Gln, Ala224Val mutations are located around the terminal N2 
cluster and can influence both the reduction of the cluster and electron transfer from N2 
to ubiquinone. In mammalian complex I, Arg118 undergoes an unusual dimethylation 
[39]. The guanidino group of the side chain is in direct contact with cluster N2. It has 
been proposed that it contributes to the relatively high reduction potential of the cluster 
[13,46]. Mutation in this position will likely impact the redox potential of the cluster. 
Arg138 similar to Arg118 is placed very close to N2 with one nitrogen of the side chain 
only 2.8Å away from the nearest sulphur of the cluster and its mutations have a 
dramatic effect on the properties of this redox center [47]. Mutation to Gln will likely 
lower the N2 redox potential and affect electron transfer rates. Although Ala224 does 
not influence the N2 cluster directly, it is placed next to His223, which was proposed to 
be the redox-Bohr group associated with the cluster [48] and like the arginines, defines 
the environment for the N2 cluster (Figure 4C).  
 
Other mutations of the NDUFS2 subunit (Asp110Val, Glu148Lys, Arg228Gln, 
Pro229Gln, Met292Thr, Arg323Gln, Arg333Gln, Ser413Pro, Met443Lys) are localized 
in regions important for the subunit’s stability or interactions with other subunits (Table 
1).  
 
NDUFS8 (TYKY) subunit  
The N-terminal end of the NDUFS8 subunit is composed of two connected amphipathic 
α-helices located on the matrix side of the internal mitochondrial membrane. One 
possible role of these α-helices is to stabilize the position of the PA relative to the lipid 
bilayer [21]. Thus, they may be important for the regulation of the proposed 
wedge/rotation like movements of the PA [20,21]. The relevance of these α-helices can 
also be demonstrated by the analysis of disease-causing substitutions. Arg54Trp, 
Glu63Gln, Arg77Trp and Pro79Leu are all located either on or in close proximity to 
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these helices. Additionally, this region of NDUFS8 is in contact with the NDUFA13 
(B16.6), ND1, NDUFA3 (B9), NDUFA7 (B14.5a) subunits and a cardiolipin molecule. 
 
Other mutations, Arg102His, Arg138His, Gly154Ser, Ala159Asp likely cause 
destabilization of Fe-S clusters. Arg102 and Arg138 are found on coils in direct contact 
with loops binding cluster N5. Ala159 is placed right next to Cys160 responsible for 
coordination of cluster N6a (Figure 4D). Pro85Leu and Arg94Cys mutations probably 
cause misassembly of the subunits (Table 1). 
 
NDUFS7 (PSST) subunit  
Val122Met and Arg145His are found on two parallel β-strands that are followed by 
loops coordinating the terminal N2 cluster. This four-strand β-sheet makes up a great 
part of the NDUFS7 subunit and is central for the stability of this region at the base of 
PA (Table 1).  
 
NDUFS3 (30kDa) and NDUFV2 (24kDa) subunits 
The NDUFS3 and NDUFV2 subunits are the only core subunits of the peripheral arm 
that do not take part directly in the main electron transfer path, but rather provide the 
platform required for complex assembly [49]. Identified disease-causing mutations 
Thr145Ile, Arg199Trp and Pro223Leu of the NDUFS3 subunit are located mostly at the 
interfaces with other subunits (Table 1). 
The single Lys209Arg substitution in the NDUFV2 subunit is localized at the very 
periphery of the PA and its role is not clear.  
 
Core Subunits of the Membrane Domain 
 
ND1 subunit 
Mutations in this subunit cause a broad spectrum of clinical features, including 
Alzheimer and Parkinson Disease, MELAS or Leigh syndrome (Table 1). Interestingly, 
the Ala52Thr mutation is one of the most frequently encountered mutations in LHON 
syndrome, identified in approximately 13% of cases (together with Arg340HisND4 
[69%] and Met64ValND6 [14%] they cause almost 95% of all cases). The broad variety 
of the diseases caused by substitutions in the ND1 region can be explained by the 
subunit’s involvement in several different functions. It contains the quinone binding 
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chamber, creates the proton input channel for the first translocation channel (the so-
called E-channel) and directly enables coupling as it links the Q-chamber with proton 
pumping modules (Box 1). Disease-causing mutations can affect all of those functions. 
Those that probably impact the accessibility to quinone are Val11Met, Glu24Lys, 
Leu28Met, Tyr30His, Met31Val, Ala52Thr, Met53Ile, Glu59Lys and Tyr227Cys. The 
conformational coupling between the Q site and the proton pumps may be affected by 
Val208Leu, Arg195Gln, Glu214Lys and Tyr215His. Mutations Ser110Asn, Ala112Thr, 
Glu143Lys, Gly131Ser and Ala132Thr are most likely to affect proton pumping activity 
of the E-channel. Additionally, substitutions Thr164Ala, Thr240Met, Leu285Pro and 
Leu289Met probably cause the enzyme’s dysfunction by affecting its structural stability 
(Figure 4E, Table 1).  
 
ND6 subunit 
Mutations in the ND6 subunit can be classified into three groups, those likely to affect 
proton translocation directly: Gly36Ser, Tyr59Cys, Met63Val, Met64Ile, Met64Val and 
Leu60Ser (Figure 4F); those affecting proton translocation indirectly: Ile26Met, 
Ala72Val and Ala74Val; and those likely to have an effect on complex I structural 
stability: Asn117Asp and Ser132Leu (Table 1). All the mutations from the first group 
are located very close to the π-bulge (disrupted secondary structure rendering α-helix 
flexible) on the highly conserved TM3, thought to be crucial for conformational 
coupling in complex I [15].  
 
ND3 subunit 
Most of the mutations in the ND3 subunit: Ser34Pro, Ser45Pro, Ala47Thr, Ile60Thr and 
Glu66Asn are found in the putative catalytically important regions. Ser34, Ser45 and 
Ala47 are all located on the long loop of ND3 that traverses the membrane domain on 
the matrix site of the mitochondria. Although none of these amino acids are conserved 
[14] they may affect the catalytic turnover of complex I indirectly, since the loop plays 
a key role in the A/D transition of the enzyme [50] and stabilises the peripheral arm / 
membrane arm interface (Box 1). 
 
Glu66 is on a TM helix next to highly conserved key TMH3ND6 and so any disturbance 
in this area may restrict/change conformational space available to TMH3ND6 [21] (Table 
1).  
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ND4L subunit 
Val65Ala and Cys32Arg are both located close to the sites crucial for proton pumping 
[21]. Val65 is situated next to the protuberance (π-bulge) of the TMH3ND6 very close to 
the key residues of ND4L and ND6. Cys32 is located next to the key Glu34 and 
Tyr69ND6 [21] (Table 1).  
 
ND2 and ND4 subunit 
All the known mutations of the ND2 subunit: Ile57Met, Leu71Pro, Gly259Ser and the 
ND4 subunit: Ile165Thr, Val313Ile, Arg340Ser, Arg340His, Tyr409His are localized in 
regions likely important for complex I stability, not catalysis. One exception is 
Arg340ND4 which interacts with the negatively charged C-terminus of the key TM7ND4, 
so the mutation may impede catalytically relevant movements of this key discontinuous 
helix (Table 1). 
 
ND5 subunit 
Mutations Phe124Leu, Glu145Gly, Ala171Val, Ala236Thr, Met237Leu, Ser250, 
Asp393Asn/Gly and Gly465Glu most likely affect the catalytic function of the ND5 
subunit. Phe145, Ala171, Ala236, Met237 build the entry channel for the protons; 
Phe124 and Ser250 influence connections of the input and output channels; while 
Asp393 and Gly465 are involved in the architecture of the output pathway. Other 
substitutions, Tyr159His and Gln434Arg probably play a more structural role (Figure 
4I, Table 1).  
 
Supernumerary Subunits Associated with the Peripheral (Matrix) Arm 
 
NDUFS6 (13kDa) subunit 
Cys115Tyr substitution is the only known single amino acid disease-causing mutation 
for this subunit and it has been previously discussed in the ovine complex I study [21]. 
Conserved Cys115 is one of the residues coordinating the zinc ion bound to this subunit 
(Box 1, Figure 4G). Mutation of Cys115 to another amino acid not only would 
destabilize the zinc-binding site, but it may also decrease electron transfer efficiency by 
disturbing the N5 cluster and perhaps affect regulatory capabilities of the system 
[21,51]. 
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NDUFA9 (39kDa) subunit 
The reported mutation Arg321Pro concerns one of the amino acids coordinating the 
NADPH molecule buried in the centre of the NDUFA9 subunit (Figure 4J). Mutation 
likely causes loss of the co-factor and distortion of the whole subunit [52], which results 
in decreased complex I activity [53]. It has been also proposed that precise positioning 
of the NADPH co-factor can indirectly regulate the function of the terminal N2 cluster 
[21]. Another mutation Arg360Cys is located on a loop forming contacts with other 
subunits.  
 
NDUFS4 (18kDa) subunit 
The disease-causing mutation Asp119His is proposed to affect the stability of the 
complex. This residue is not likely to play a catalytic role but it has been shown that 
subunit NDUFS4 is important for the assembly of the complex [37] (Table 1). 
 
Supernumerary Subunits Associated with the Membrane Domain 
 
NDUFA10 (42kDa) and NDUFB9 (B22) subunits 
These subunits are located on the matrix side of the membrane domain. The disease-
causing mutation Gly99GluNDUFA10 is located at the interface with the ND2 and 
NDUFC1 (KFYI) subunits, so it may decrease the stability of the complex in this 
region. The Gln142ArgNDUFA10 mutation is found in the central α-helix of the subunit, 
within the nucleotide kinase fold and most likely affects the structure (Figure 4L).  
One mutation of NDUFB9 is reported to cause complex I deficiency (Table 1) and it is 
likely to influence subunit assembly. This mutation (Leu64Pro) occurs at the last α-
helix of the NDUFB9 helical bundle accommodating the phosphopantetheine (PNS) co-
factor covalently bound to the NDUFB9’s interacting partner NDUFAB1-β (SDAP-β) 
subunit (Box 1). A mutation to proline in the middle of the helix can affect the structure 
of the PNS hydrophobic pocket and alter the NDUFAB1/NDUFB9 complex causing 
destabilization of this region (Figure 4H).  
 
NDUFA1 (MWFE), NDUFA8 (PGIV) and NDUFA13 (B16.6) subunits 
These subunits are located mostly on the IMS site of the membrane domain. They 
mostly play stabilizing roles, important for enzyme assembly [37]. Reported disease-
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causing mutations Gly8Arg, Gly32Arg, Arg37Ser, Tyr43His of NDUFA1 and Lys5Asn 
of NDUFA13 are mainly located on the interfaces with other complex I subunits (Figure 
4K, Table 1). The reported mutation 325G>A in the NDUFA8 gene results in 
Glu109Lys substitution. However, in position 109 Lys is a natural variant in some 
mammals (e.g. Ovis Aries) [24]. It is likely that the mutation does not strongly affect 
the protein but causes instability of the NDUFA8 gene transcript [54]. 
 
  
Concluding Remarks and Future Perspectives. 
 
There is no cure for complex I related diseases. The current best treatment is to optimize 
nutrition and reduce physiological stress. Pharmacological treatment includes 
supplementation with CoQ, riboflavin, L-creatine, L-arginine, L-carnitine and vitamins: 
B1, C, E and folinic acid (reduced form of folic acid) [55]. The recent structures of 
mitochondrial complex I have already provided a great insight into its mechanism and 
function. They improved not only our understanding of the very basic processes in our 
cells – ATP production - but can also become a starting point for structure-based, in-
silico design of the new type of molecules for a better treatment of patients suffering 
from complex I deficiency [56]. 
  
Recent progress was accomplished thanks to the latest developments in cryo-EM [57]. 
Currently, only single particle cryo-EM allows achievement of resolutions high enough 
to obtain maps of mammalian complex I interpretable on the atomic scale. One of the 
main remaining questions in the field is the exact nature of the enzyme’s coupling 
mechanism (see “Outstanding Questions”). It can be studied by determining the 
structures of complex I in different redox states and in the presence of various 
substrates/inhibitors, visualizing conformational changes underlying coupling 
mechanism. Another question is on the role of respiratory supercomplexes, a dominant 
physiological state of the electron transport chain [25]. It is not yet clear if they provide 
any kinetic advantage for the respiratory reactions or mainly stabilize individual 
complexes or perhaps limit ROS production [26]. Atomic structures of the 
supercomplexes (CI+CIII2, CI+CIII2+CIV, CIII2+CIVn, etc) are being determined 
[22,23], however, inter-complex contacts at the side-chain level are not yet established 
due to limited resolution in the reconstructions of the entire assemblies. This precludes 
	   14	  
the detailed analysis of the role of individual residues in such contacts. Cryo-electron 
tomography already allows us to look at the respiratory chain enzymes 
(supercomplexes) in the native lipid environment, albeit at low resolution so far [58,59]. 
This will continue to improve and will provide complementary information to the 
structures coming from single particle analysis. Further developments in cryo-EM 
technology will undoubtedly continue to provide us with exciting new knowledge on 
the organisation of the respiratory chain. 
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Table 1. Summary of single amino acid substitutions causing complex I 
deficiency. 
 
Subunit 
name	  
Human/	  
Bovine	  
Location	  
Mutation 
(residue # in 
nuclear-
encoded 
mature 
subunit) 
Remaining 
activity of 
complex I 
(%) 
Additional 
comments Reported clinical feature 
Proposed reason for complex 
I dysfunction	   Reference	  
NDUFS1
/	  
75kDa 
 
Periphera
l domain/	  
core	  
Val71Asp 
(48) <50  
Miscellaneous: raised 
blood lactate, raised CSF 
lactate, muscular 
hypotonia, psychomotor 
development delay 
Disruption of electron 
transfer at N1b and N3 
clusters site; located close to 
the clusters in a loop 
interacting with cluster-
coordinating chains.	  
[60]	  
Gly166Glu 
(143) <50  
Miscellaneous: optic 
atrophy, psychomotor 
regression, nystagmus, 
dystonia and dysphagia, 
leukodystrophy, brain 
atrophy, symmetrical 
lesions affecting pons and 
medulla oblongata 
Disruption of electron 
transfer at N1b cluster site; 
located close to the cluster, 
part of a loop followed by a 
β-sheet and a coil that binds 
N1b cluster	  
[61]	  
Val228Ala 
(205) >50 
Accumulation of 
subcomplexes 
Leukoencephalomyelopath
y 
Disruption of electron 
transfer at N1b and N3 
clusters site; located in a 
loop between the N3 and 
N1b clusters 5.4 Å and 3.9 Å 
away respectively	  
[62-64]	  
Leu231Val 
(208) 25  Leigh syndrome 
Disruption of electron 
transfer at N4 cluster site	   [65]	  
Arg241Trp 
(218) 77 
Oxidation of NADH-
generating substrates 
was low in muscle 
mitochondria, in 
fibroblasts, and in 
circulating 
lymphocytes 
Miscellaneous: growth 
retardation, axial 
hypotonia, hepatomegaly, 
persistent hyperlactatemia, 
hyperintensity of basal 
ganglia, macrocytic anemia 
and dystonia 
Disruption of electron 
transfer at N5 and N6 
clusters site; side chain ~3Å 
away from cysteines 
coordinating these clusters	  
[66]	  
Asp252Gly 
(229) 67 
A complex I 
deficiency was 
identified in muscle 
and liver. Decreased 
NADH-generating 
substrates oxidation 
in fibroblasts 
suggested a complex 
I deficiency. 
Lymphocytes were 
normal 
Leukoencephalomyelopath
y 
Affected assembly due to 
misfolding of NDUFS1 
subunit; located in region 
central for proper folding of 
the subunit	  
[62,66] 
Arg408Cys 
(385) <30 
Accumulation of 
subcomplexes 
Leukoencephalomyelopath
y 
Affected assembly due to 
misfolding of NDUFS1 
subunit; located in region 
central for proper folding of 
the subunit	  
[64]	  
Gln522Lys 
(499) 45 
Formation of ~800 
kDa subcomplex ; 
increased level of 
ROS production , 
affinity for NADH 
Leukoencephalomyelopath
y 
Affected assembly due to 
misfolding of NDUFS1 
subunit; located in region 
central for proper folding of 
the subunit 
[54]	  
Thr595Ala 
(572) <50  
Leukoencephalomyelopath
y 
Affected assembly due to 
misfolding of NDUFS1 
subunit 
[67]	  
Asp619Asn 
(596) <30 
Accumulation of 
subcomplexes 
Isolated enzymatic 
complex I deficiency 
confirmed in both muscle 
tissue and cultured 
fibroblasts 
Affected assembly due to 
impaired interaction of 
NDUFS1 and NDUFA6 
(B14) subunits; in a loop 
close to the 
NDUFS1/NDUFA6 
interface	  
[64,68]	  
Tyr695His 
(672) <50  
Miscellaneous: raised 
blood lactate, 
leukodystrophy, lactate 
raised in brain, loss of 
neurological abilities 
Affected assembly due to 
misfolding of NDUFS1 
subunit; close to Met707	  
[60,63]	  
	  
Tyr695Cys 
(672) <50  
Miscellaneous: raised 
blood lactate, 
leukodystrophy, lactate 
raised in brain, loss of 
neurological abilities 
Affected assembly due to 
misfolding of NDUFS1 
subunit; close to Met707	  
[60]	  
Met707Val 
(684) 50 
A complex I 
deficiency was 
identified in muscle. 
Cultured skin 
fibroblasts oxidized 
NADH-generating 
substrates normally 
Miscellaneous: hypotonia, 
microcephalia, and 
pyramidal syndrome, 
Leigh syndrome, and 
permanent anemia 
Affected assembly due to 
misfolding of NDUFS1 
subunit; close to Tyr695	  
[66]	  
NDUFV
1/	  
51kDa	  
Periphera
l domain/	  
core	  
Ser56Pro 
(36) <50  
Miscellaneous: brain 
abnormalities, motor delay 
including pyramidal signs, 
hypotonia and a mild 
ataxia, minor cognitive 
impairment 
Affected assembly due to 
impaired interaction of 
NDUFV1, NDUFV3 
(10kDa) and NDUFV2 
subunits, located at α-helix 
that makes interactions with 
the NDUFV3 and C-terminal 
extension of NDUFV2 
subunit 
[4]	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Arg88Gly 
(68) N/A 
A muscle biopsy was 
inconclusive, no 
clear changes of a 
mitochondrial 
cytopathy 
Leigh syndrome 
Disruption of electron 
transfer at FMN site; builds 
the pocket for FMN binding 
[69]	  
Pro122Leu 
(102)b <20  
Miscellaneous: stroke, 
exercise intolerance, 
dyspnoea, leukodystrophy 
Disruption of electron 
transfer at FMN and N1a 
cluster sites; located in a 
loop between FMN and 
cluster N1a 
[70]	  
Arg199Pro 
(179) N/A 
Arginine was 
conserved at position 
199 in all 46 other 
vertebrate species 
analyzed 
Leigh syndrome 
Affected assembly due to 
impaired interaction of 
NDUFV1, NDUFV3 and 
NDUFV2 subunits; located 
in a β-strand interacting with 
the NDUFV3 and NDUFV2 
subunits 
[69]	  
Tyr204Cys 
(184) 30 
A complex I 
deficiency was 
identified in muscle. 
Oxidation of NADH-
generating substrates 
was normal in both 
cultured skin 
fibroblasts and 
circulating 
lymphocytes 
Miscellaneous: ptosis and 
strabismus, ataxia, bilateral 
ptosis, ophthalmoplegia, 
metabolic acidosis, 
hyperintensity of the locus 
niger 
Disruption of electron 
transfer at FMN site; builds 
the pocket for FMN binding 
[66]	  
Cys206Gly 
(186) 30 
A complex I 
deficiency was 
identified in muscle. 
Oxidation of NADH-
generating substrates 
was normal in both 
cultured skin 
fibroblasts and 
circulating 
lymphocytes 
Miscellaneous: ptosis and 
strabismus, ataxia, bilateral 
ptosis, ophthalmoplegia, 
metabolic acidosis, 
hyperintensity of the locus 
niger 
Disruption of electron 
transfer at FMN site; placed 
close to residues crucial for 
FMN and NADH binding 
including Glu189 
[66]	  
Ala211Val 
(191) <55 
A complex I 
deficiency was 
identified in cultured 
decidual cells. No 
deficiency in native 
chorionic villi nor 
muscle (aborted 
fetus) 
Miscellaneous: brain 
abnormalities, motor delay 
including pyramidal signs, 
hypotonia and a mild 
ataxia, minor cognitive 
impairment 
Disruption of electron 
transfer at FMN and N3 
cluster sites; located very 
close to FMN and N3 
coordinating residues 
[71] 
Glu214Lys 
(194) 50 
A complex I 
deficiency was 
identified in muscle 
and liver. Oxidation 
of NADH-generating 
substrates was 
normal in cultured 
skin fibroblasts. 
Miscellaneous: 
acrocyanosis, muscular 
hypotonia, pendular 
nystagmus, bitemporal 
retinal depigmentation, 
increased latencies of the 
visual evoked potentials, 
lactic acidosis 
Disruption of electron 
transfer at FMN and N3 
cluster sites and affected 
assembly due to impaired 
interaction of NDUFV1 and 
NDUFS1 subunits; placed in 
between coils stabilizing 
FMN and binding cluster N3 
[66]	  
Ala341Val 
(321) <36 
Isolated complex I 
deficiency was 
detected in muscle, 
data form cultured 
fibroblasts 
inconsistent 
Miscellaneous: infantile 
myoclonic epilepsy, 
spasticity, macrocephaly, 
brain atrophy, 
leukodystrophy, blindness 
Disruption of electron 
transfer at FMN site due to 
possible distortion of the 
NADH-binding pocket 
[54,72]	  
Arg386Cys 
(366) <40 
Complex I assay (n-
decyl CoQ) 0% 
Complex I assay 
(CoQ1) 38% 
Leukoencephalomyelopath
y 
Disruption of electron 
transfer at N3 cluster site 
and affected assembly due to 
misfolding of NDUFV1 
subunit; located next to the 
conserved Cys385 
coordinating cluster N3 
[73]	  
Thr423Met 
(403) N/A  Broad spectrum 
Disruption of electron 
transfer at N3 cluster site 
and affected assembly due to 
misfolding of NDUFV1 
subunit; located next to the 
conserved Cys425 
coordinating cluster N3 
[72]	  
Ala432Pro 
(412) 50 
A complex I 
deficiency was 
identified in muscle 
and liver. Oxidation 
of NADH-generating 
substrates was 
normal in cultured 
skin fibroblasts. 
Miscellaneous: vomiting, 
hypotonia, lethargy, apnea, 
metabolic acidosis, 
hyperintensity in the basal 
ganglia 
Disruption of electron 
transfer at N3 cluster site 
due to distortion of the α-
helix directly linked to the 
conserved Cys425 
coordinating cluster N3 
[66]	  
NDUFS2
/	  
49kDa	  
Periphera
l domain/	  
core	  
Asp110Val 
(77) <25  Cardiomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFS2, NDUFS3, 
NDUFS7 and ND1 subunits; 
located in the middle of a β-
strand that is part of a β-
sheet interacting with the 
NDUFS3, NDUFS7 and 
ND1 subunits 
[60]	  
Arg118Gln 
(85) 20 
heterozygous 
mutation 
in addition to 
NDUFS2/ 
Met292Thr 
Leigh syndrome 
Disruption of electron 
transfer at N2 cluster site, 
affects the redox potential of 
the cluster 
[9]	  
Arg138Gln 
(105) 16 
heterozygous 
mutation 
same patient as 
NDUFS2/ 
Arg333Gln 
Leigh syndrome 
Disruption of electron 
transfer at N2 cluster site, 
affects the redox potential of 
the cluster 
[9]	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Glu148Lys 
(115) 13 
heterozygous 
mutation 
in addition to 
NDUFS2/ 
Met292Thr 
Leigh syndrome 
Affected assembly due to 
misfolding of NDUFS2 
subunit; located at an α-helix 
in the center of the NDUFS2 
subunit 
[9]	  
Ala224Val 
(191) 13 
complex I activity 
was markedly low in 
muscle but was 
normal in cultured 
fibroblasts 
Miscellaneous: neonatal 
hypotonia, dysmorphic 
features, epilepsy and signs 
of brainstem involvement, 
lactic acidosis 
Disruption of electron 
transfer at N2 cluster site; 
placed next to His190, which 
was proposed to be the 
redox-Bohr group associated 
with the cluster 
[54]	  
Arg228Gln 
(195) <60  
Cardiomyopathy and 
encephalomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFS2 and NDUFS8 
subunits; located close to the 
interface with NDUFS8 
subunit 
[74]	  
Pro229Gln 
(196) <36  
Cardiomyopathy and 
encephalomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFS2 and NDUFS8 
subunits; located close to the 
interface with NDUFS8 
subunit 
[74]	  
Met292Thr 
(259) <30  Leigh syndrome 
Affected assembly due to 
impaired interaction of 
NDUFS2, NDUFS3, 
NDUFA5 (B13), NDUFC2 
(B14.5b) and NDUFS8 
subunits 
[9,75]	  
Arg323Gln 
(290) <25  Cardiomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFS2, NDUFA5 and 
NDUFS8 subunits 
[63]	  
Arg333Gln 
(300) 16 
heterozygous 
mutation 
same patient as 
NDUFS2/ 
Arg138Gln 
Leigh syndrome 
Affected assembly due to 
impaired interaction of 
NDUFS2, NDUFA13, 
NDUFA7 and NDUFS8 
subunits 
[9]	  
Ser413Pro 
(380) <70  
Cardiomyopathy and 
encephalomyopathy 
Affected assembly due to 
misfolding of NDUFS2 
subunit and impaired 
interaction of NDUFS2 and 
NDUFS3 subunits; on a β-
strand interacting with 
NDUFS3 subunit 
[74]	  
Met443Lys 
(410) 27 
heterozygous 
mutation 
in addition to 
NDUFS2/ 
Met292Thr 
Leigh syndrome 
Affected assembly due to 
impaired interaction of 
NDUFS2 and ND1 subunits, 
located at the interface with 
ND1 subunit 
[9]	  
Asp446Asnc 
(413) 26  
Miscellaneous: basal 
ganglia and brainstem 
lesions, seizures, 
hypotonia, amaurosis, 
nystagmus 
Affected assembly due to 
interaction of NDUFS2 and 
ND1 subunits, located at the 
interface with ND1 subunit 
[76]	  
NDUFS3
/	  
30kDa	  
Periphera
l domain/	  
core	  
Thr145Ile 
(109) 50  Leigh syndrome 
Affected assembly due to 
misfolding of NDUFS3 
subunit, close to the center 
of a β-sheet forming most of 
the NDUFS3 subunit 
[77]	  
Arg199Trp 
(163) 50  Leigh syndrome 
Affected assembly due to 
impaired interaction of 
NDUFS3, NDUFS2 and 
NDUFS4 subunits; found in 
a loop that directly contacts 
the NDUFS2 and NDUFS4 
subunits 
[77]	  
Pro223Leu 
(187) 14  Encephalomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFS3, NDUFS2, 
NDUFS7 and NDUFA6 
subunits; found at the end of 
a loop located in between the 
NDUFS7, NDUFS2 and 
NDUFA6 subunits 
[62]	  
NDUFV
2/	  
24kDa	  
Periphera
l domain/	  
core	  
Lys209Arg 
(177) N/A  Parkinson disease 
Not clear, located at 
peripheral α-helix of the 
complex 
[78]	  
NDUFS8 
TYKY	  
Periphera
l domain/	  
core	  
Arg54Trp 
(20) 29  
Progressive external 
ophthalmoplegia and Leigh 
syndrome 
Affected assembly due to 
misfolding of NDUFS8 
subunit; located at a 
stabilizing amphipathic α-
helix 
[79]	  
Glu63Gln 
(29) <20  Leigh syndrome 
Affected assembly due to 
misfolding of NDUFS8 
subunit; located at a 
stabilizing amphipathic α-
helix 
[63]	  
Arg77Trp 
(43) <55  
Cardiomyopathy and 
encephalomyopathy 
Affected assembly due to 
misfolding of NDUFS8 
subunit; located close to a 
stabilizing amphipathic α-
helix 
[63]	  
Pro79Leu 
(45) 39 
Value for the muscle 
tissue, complex I 
deficiency also 
reported for skin 
fibroblasts, heart, 
liver and brain 
Leigh syndrome 
Affected assembly due to 
misfolding of NDUFS8 
subunit; located close to a 
stabilizing amphipathic α-
helix 
[80]	  
	   18	  
tissues 
Pro85Leu 
(51) <43 
WB analysis showed 
decreased amounts 
of the NDUFS8 
protein and other 
nuclear-encoded 
complex I subunits 
Leigh syndrome 
Affected assembly due to 
impaired interaction of 
NDUFS8, NDUFA12 
(B17.2) and NDUFS7 
subunits; located at the loop 
interacting with the 
NDUFA12 and NDUFS7 
subunits 
[81]	  
Arg94Cys 
(60) 18 	  
Complex I deficiency 
report based on muscle 
tissue as well as in cultured 
fibroblasts 
Affected assembly due to 
impaired interaction of 
NDUFS8 and NDUFS2 
subunits; found in a loop 
making the interface with 
the NDUFS2 subunit 
[76,82]	  
Arg102His 
(68) 39 
Value for the muscle 
tissue, complex I 
deficiency also 
reported for skin 
fibroblasts, heart, 
liver and brain 
tissues 
Leigh syndrome 
Disruption of electron 
transfer at N5 cluster site; 
stabilizes loop coordinating 
cluster N5 
[80]	  
Arg138His 
(104) <43 
WB analysis showed 
decreased amounts 
of the NDUFS8 
protein and other 
nuclear-encoded 
complex I subunits 
Leigh syndrome 
Disruption of electron 
transfer at N5 cluster site;  
stabilizes another loop 
coordinating cluster N5 
[81]	  
Ala159Asp 
(125) <55  
Cardiomyopathy and 
encephalomyopathy 
Disruption of electron 
transfer at N6a cluster site; 
placed next to Cys126 
coordinating cluster N6a. 
Mutation will likely decrease 
redox potential of N6a. 
[63]	  
NDUFS7	  
PSST	  
Periphera
l domain/	  
core	  
Val122Met 
(84) <80  Leigh syndrome 
Disruption of electron 
transfer at N2 cluster site 
and affected assembly due to 
misfolding of NDUFS7 
subunit; located on β-strand 
followed by a loop 
approaching the N2 cluster 
[83]	  
Arg145His 
(107) 62  Leigh syndrome 
Disruption of electron 
transfer at N2 cluster site 
and affected assembly due to 
misfolding of NDUFS7 
subunit; located on β-strand 
followed by a loop 
coordinating the N2 cluster 
[84]	  
MT-ND6	  
ND6	  
Membran
e domain/	  
core	  
Ile26Met 21  Leber hereditary optic atrophy 
Disturbance of catalytically 
important TMH1-2ND3 loop 
or TMH3ND6 
[85] 	  
Gly36Ser N/A  Leber hereditary optic atrophy 
Disruption of proton 
translocation through the E-
channel, facing π-bulge on a 
highly conserved TMH3 
[85,86]	  
Tyr59Cys N/A  Leber hereditary optic atrophy 
Disruption of proton 
translocation through the E-
channel,  sits on a π-bulge 
from a highly conserved 
TMH3, Tyr proposed to be 
crucial for proton 
translocation 
[85,86]	  
Leu60Ser N/A  Leber hereditary optic atrophy 
Disruption of proton 
translocation through the E-
channel, located on a highly 
conserved TMH3 
[85,87]	  
Met63Val <25 
Low complex I 
activity in muscles, 
normal in fibroblasts 
Leigh syndrome 
Disruption of proton 
translocation through the E-
channel, located on a highly 
conserved TMH3 
[54] 
Met64Val N/A Increased inhibitor sensitivity 
Leber hereditary optic 
atrophy 
Disruption of proton 
translocation through the E-
channel, located on a highly 
conserved TMH3 
[88,89]	  
Met64Ile N/A  Leber hereditary optic atrophy 
Disruption of proton 
translocation through the E-
channel, located on a highly 
conserved TMH3 
[60,85,90]	  
Ala72Val 5  
Miscellaneous: juvenile 
myopathy, encephalopathy, 
lactic acidosis, stroke 
Disturbance of catalytically 
important TMH1-2ND3 loop 
or TMH3ND6 
[91,92]	  
Ala74Val 33  
Miscellaneous: Leber 
hereditary optic atrophy 
with dystonia, Leigh 
syndrome 
Disturbance of catalytically 
important TMH1-2ND3 loop 
or TMH3ND6 
[93,94]	  
Asn117Asp N/A 
The substitution is a 
candidate LHON 
mutation, but the 
available evidence is 
not definitive 
Leber hereditary optic 
atrophy 
Affected assembly due to 
impaired interaction of ND6, 
ND5, ND4L and ND2 
subunits; located in a loop 
contacting ND5, ND4L and 
ND2 
[95]	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Ser132Leu N/A  Leber hereditary optic atrophy 
Affected assembly due to 
impaired interactions of 
subunits at the "heel" of 
complex I; located at the 
interface with several 
supernumerary subunits 
[96]	  
MT-ND5	  
ND5	  
Membran
e domain/	  
core 
Phe124Leu <35 
Mutation present at 
levels of 43% load in 
skeletal muscle and 
30% mutant load in 
skin fibroblasts 
Leigh syndrome 
Disruption of proton 
translocation through the 
ND5 channel; placed in the 
middle of TMH4, in contact 
with the residues at the 
crucial π-bulge of TMH8 
[97]	  
Glu145Gly 100 
Mutation present at 
48% in muscle and 
15% in blood 
MELAS 
Disruption of proton 
translocation through the 
ND5 channel; one of the key 
residues accepting protons 
from the matrix side 
[98]	  
Tyr159His N/A 
Located in 
evolutionary not 
conserved region 
Leber hereditary optic 
atrophy 
Affected assembly due to 
impaired interaction of ND5 
and ND4 subunits; directly 
interacts with ND4 residues 
on the matrix site of the 
membrane 
[99]	  
Ala171Val N/A  Leber hereditary optic atrophy 
Disruption of proton 
translocation through the 
ND5 channel; located close 
to the cavity making an entry 
point for protons 
[100]	  
Ala236Thr 23  MELAS, Leigh syndrome  
Disruption of proton 
translocation through the 
ND5 channel; located close 
to the cavity making an entry 
point for protons 
[101]	  
Met237Leu Mild defect 
Mutation present at 
82% in muscle and 
13% in blood 
Miscellaneous: Leber 
hereditary optic atrophy, 
MELAS, Leigh syndrome 
Disruption of proton 
translocation through the 
ND5 channel; located close 
to the cavity making an entry 
point for protons 
[98]	  
Ser250Cys Partial CI deficiency 
The mutation was 
detected in a 
heteroplasmic state 
in the lymphocytes 
of the patient's 
mother (57%), who 
had migraine and 
optic atrophy, and 
younger sister (41%) 
MELAS, Leigh syndrome 
Disruption of proton 
translocation through the 
ND5 channel; located at the  
crucial π-bulge of TMH8 
[102]	  
Asp393Asn 15 
Normal activity in 
fibroblasts, reduced 
WB signal for 
NDUFS7 and 
NDUFB6 
MELAS, Leigh syndrome 
Disruption of proton 
translocation through the 
ND5 channel; placed next to 
the key Lys392 and builds 
the proton outlet cavity 
[54,103]	  
Asp393Gly 39 
Normal activity in 
fibroblasts, reduced 
WB signal for 
NDUFS7 and 
NDUFB6 
Leigh syndrome 
Disruption of proton 
translocation through the 
ND5 channel, placed next to 
the key Lys392 and builds 
the proton outlet cavity 
[54]	  
Gln434Arg N/A 
The substitution is a 
regarded as a 
possible risk factor 
for LHON that could 
contribute to the 
clinical 
manifestation of this 
disease under certain 
conditions 
Leber hereditary optic 
atrophy 
Affected assembly due to 
impaired interaction of ND5, 
NDUFB3 (B12) and 
NDUFB9 subunits, found on 
a loop that is in direct 
contact with NDUFB3 and 
NDUFB9 subunits 
[104] 
Gly465Glu N/A 
Mutation present in 
approximately 80% 
of the mtDNA 
molecules 
Leber hereditary optic 
atrophy 
Affected assembly due to 
misfolding of ND5 subunit; 
located directly opposite to 
the loop linking two half 
helices of TMH12 
[105]	  
MT-
ND4L	  
ND4L	  
Membran
e domain/ 	  
core	  
Cys32Arg N/A  Familial colorectal cancer 
Disruption of proton 
translocation through the E-
channel; located next to the 
key Glu34 and Tyr59ND6 
[106]	  
Val65Ala Partial CI defect  
Leber hereditary optic 
atrophy 
Disruption of proton 
translocation through the E-
channel; situated next to the 
π-bulge of the TMH3 of 
ND6, close to the key 
residues of ND4L and ND6 
subunits 
[107]	  
MT-ND4	  
ND4 
Membran
e domain/  
core 
Ile165Thr N/A  Leber hereditary optic atrophy 
Affected assembly due to 
impaired interaction of ND4 
and ND2 subunits; placed at 
the C-terminal end of an α-
helix forming the main 
interaction site with ND2 
subunit 
[108]	  
Val313Ile 21  
Miscellaneous: Leber 
hereditary optic atrophy, 
Leber hereditary optic 
neuropathy with dystonia 
Affected assembly due to 
misfolding of ND4 subunit; 
found on TMH12 far from 
the proton translocation site 
[85]	  
Arg340Ser <45 Resistance to rotenone in humans Leigh syndrome 
Affected assembly due to 
misfolding of ND4 subunit; 
located at a loop in contact 
with the TMH10-11 loop 
and NDUFB4 (B15) subunit. 
Arg340 interacts with the 
negatively charged C-
[54,109,110
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terminus of the key TM7ND4, 
so the mutation may impede 
catalytically relevant 
movements of this 
discontinuous helix. 
Arg340His <25  Leber hereditary optic atrophy 
Affected assembly due to 
misfolding of ND4 subunit, 
located at a loop in contact 
with the TMH10-11 loop 
and NDUFB4 subunit. 
Arg340 interacts with the 
negatively charged C-
terminus of the key TM7ND4, 
so the mutation may impede 
catalytically relevant 
movements of this 
discontinuous helix. 
[5,7,111]  
Tyr409His >100 
 NADH 
dehydrogenase and 
succinate 
dehydrogenase 
(SDH) activities 
increased 
Leigh syndrome 
Affected assembly due to 
impaired interaction of ND4 
and NDUFB8 subunits  
[112]	  
MT-ND3	  
ND3	  
Membran
e domain/ 	  
core	  
Ser34Pro <20  Leigh syndrome 
Affected complex I 
active/deactive state 
transition, located at a loop 
crucial for the A/D transition 
of the enzyme 
[54,113]	  
Ser45Pro <25  Leigh syndrome 
Affected complex I 
active/deactive state 
transition, located at a loop 
crucial for the A/D transition 
of the enzyme 
[54,113]	  
Ala47Thr 12 
Activity from muscle 
homogenate. 
Variable degrees of 
heteroplasmy and 
complex I activity 
were found in all 
tissues 
Leber optic neuropathy 
with dystonia, Leigh 
syndrome 
Affected complex I 
active/deactive state 
transition, located at a loop 
crucial for the A/D transition 
of the enzyme 
[10]	  
Ile60Thr N/A  Leber hereditary optic atrophy 
Affected assembly due to 
impaired interaction of ND3, 
ND4L and ND6 subunits; 
placed off the proton 
translocation site with the 
side chain at the interface 
with ND4L and ND6 
subunits 
[114] 
Glu66Asn <65  Leigh syndrome 
Affected assembly due to 
impaired interaction of ND3, 
ND1 and ND6 subunits; 
located at a TMH forming 
interaction with ND1 and 
ND6 subunits 
[115]	  
MT-ND2	  
ND2	  
Membran
e domain/ 	  
core	  
Ile57Met 100 
Biochemical analysis 
of complex I in 
patient lymphoblasts 
and 
transmitochondrial 
cybrids demonstrated 
a respiration defect 
with complex-I-
linked substrates, 
although the specific 
activity of complex I 
was not reduced 
Leber hereditary optic 
atrophy 
Affected assembly due to 
impaired interaction of ND2 
and ND4L subunits; placed 
at the interface with ND4L 
subunit 
[116]	  
Leu71Pro 51 
Accumulation of the 
membrane arm 
assembly 
intermediate 400 
kDa and the 
peripheral arm 
assembly 600 kDa 
subcomplexes  
Leigh syndrome 
TM6 likely distorted. 
Affected assembly due to 
impaired interaction with 
ND4L subunit 
[117]	  
Gly259Ser N/A 
Resistance to 
rotenone in humans, 
90% activity E. coli 
Leber hereditary optic 
atrophy 
Disruption of proton 
translocation through the 
ND2 channel; located on the 
loop in the center of the 
broken TMH12, close to the 
key Lys263 
[118,119] 	  
MT-ND1	  
ND1	  
Membran
e domain/ 	  
core	  
Val11Met <70 
co-segregates with 
tRNALeu(CUN) 
A12308G and 
tRNAThr C15946T 
mutations 
Leber hereditary optic 
atrophy 
Disruption of electron 
transfer by obstruction of Q 
entry site; located at the first 
TM helix building entry 
channel for quinone 
[120]	  
Glu24Lys <40  Leber hereditary optic atrophy 
Disruption of electron 
transfer by distortion of Q 
entry site; located at the first 
TM helix building entry 
channel for quinone 
[121] 
Leu28Met 40 Decrease in complex I protein level Deafness 
Disruption of electron 
transfer by distortion of Q 
entry site; located at the first 
TM helix building entry 
channel for quinone 
[122]	  
Tyr30His N/A  Leber hereditary optic atrophy 
Disruption of electron 
transfer by distortion of Q 
entry site; located at the first 
TM helix building entry 
channel for quinone 
[123]	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Met31Val N/A  Alzheimer and Parkinson disease 
Disruption of electron 
transfer by distortion of Q 
entry site; located at the first 
TM helix building entry 
channel for quinone 
[124]	  
Ala52Thr <39  Leber hereditary optic atrophy 
Disruption of electron 
transfer by obstruction of Q 
entry site; located at 
amphipathic α-helix building 
entry channel for quinone 
[125] 
Met53Ile N/A  Leber hereditary optic atrophy, Leigh syndrome 
Disruption of electron 
transfer by obstruction of Q 
entry site; located at 
amphipathic α-helix building 
entry channel for quinone 
[126]	  
Glu59Lys N/A  Leigh syndrome 
Disruption of electron 
transfer by distortion of Q 
entry site; located at 
amphipathic α-helix building 
entry channel for quinone 
[127]	  
Ser110Asn 100 
Respiration defect 
with complex I-
linked substrates in 
patient lymphoblasts 
and trans-
mitochondrial 
cybrids, but specific 
activity of complex I 
was not reduced 
Leber hereditary optic 
atrophy 
Possible disruption of proton 
translocation pathway 
through the E-channel 
[116]	  
Ala112Thr N/A  Leber hereditary optic atrophy 
Disruption of proton 
translocation through the E-
channel 
[109] 
Gly131Ser 40 
Complex I activity 
decreased in 
fibroblasts but 
normal in muscles 
MELAS, Leber hereditary 
optic atrophy 
Possible distortion of Q-
binding cavity; interacts with 
the key TMH5-6 loop lining 
the cavity 
[128]	  
Ala132Thr N/A  Leber hereditary optic atrophy 
Possible distortion of Q-
binding cavity; interacts with 
the key TMH5-6 loop lining 
the cavity 
[129] 
Glu143Lys N/A  Leber hereditary optic atrophy 
Disruption of proton 
translocation through the E-
channel, connects half-
channels of the proton 
translocation unit 
[130]	  
Ala164Thr Decreased CI activity  Dystonia 
Affected assembly due to 
misfolding of ND1 subunit; 
located in the center of a 
short α-helix stabilizing 
TMHs 2-6 
[131]	  
Arg195Gln <60  Leigh syndrome Disruption of quinone binding; lines the Q-cavity [127]	  
Val208Leu <80 Complex I assembly intact Leigh syndrome 
Impairment of coupling, 
located in the region 
proposed to link quinone 
reduction and proton 
pumping sites 
[132]	  
Glu214Lys <63  MELAS 
Impairment of coupling, 
located in the region 
proposed to link quinone 
reduction and proton 
pumping sites 
[128]	  
Tyr215His 63  MELAS 
Impairment of coupling, 
located in the region 
proposed to link quinone 
reduction and proton 
pumping sites 
[128]	  
Thr240Met N/A  Leber hereditary optic atrophy 
Affected assembly or 
destabilization of ND1 
subunit, located at the C-
terminus of the TMH6 
[99]	  
Tyr227Cys 14  Leber hereditary optic atrophy 
Disruption of electron 
transfer by distortion of Q 
entry site; located on TMH6, 
framing the entry site 
[125]	  
Leu285Pro 27  Leber hereditary optic atrophy 
Affected assembly due to 
impaired interactions of 
ND1 with ND3 and 
NDUFS2 subunits  
[125] 
Leu289Met N/A  Leber hereditary optic atrophy 
Affected assembly due to 
impaired interactions of 
ND1 with ND3 subunit 
[133] 
NDUFS4	  
18kDa	  
Periphera
l domain/ 
supernum
erary	  
Asp119His 
(77) 63 
Reduction in 
complex I activity in 
muscle homogenate 
but normal activities 
in cultured 
fibroblasts 
Leigh syndrome 
 
Affected assembly due to 
impaired interaction of 
NDUFS4, NDUFA9, 
NDUFV1 and NDUFS1 
subunits; located on a loop 
anchored in between the 
neighboring NDUFS3, 
NDUFV1, NDUFS1 core 
subunits 
 
[134]	  
NDUFS6	  
13kDa	  
Periphera
l domain/ 
supernum
erary	  
Cys115Tyr 
(87) <22  
Fatal neonatal lactic 
acidemia 
 
Affected assembly due to 
misfolding of 13kDa subunit 
and disruption of electron 
transfer at N5 cluster site; 
one of the amino acids 
coordinating Zn ion 
	  
[135]	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ain ovine complex I lysine is the natural variant in this position 
bdescribed as ‘P113L’ 
cdescribed as ‘D445N’ 
ddescribed as ‘K88N’ 
LHON, Leber’s hereditary optic neuropathy; MELAS, childhood-onset 
mitochondrial encephalomyopathy and lactic acidosis and stroke-like episodes 
syndrome; PNS, phosphopantetheine; Q, ubiquinone; WB, western blot. 
 
 
 
Box 1 Putative mechanism of coupling between electron transfer and proton 
translocation in mammalian complex I.  
 
 The proposed mechanism [15,21] involves long-range conformational changes, 
allowing for redox energy of electron transfer, released in the peripheral (matrix) arm, 
to be used to drive proton translocation in the membrane arm. The electron transfer 
pathway begins with NADH donating two electrons to a flavin mononucleotide (FMN) 
molecule bound at the tip of the peripheral arm (Figures 1 and I). These electrons are 
then transferred in turn via a chain of seven iron-sulfur (FeS) clusters to ubiquinone (Q) 
bound at the interface between the peripheral and membrane arms. Upon electron 
NDUFA
9	  
39kDa	  
Periphera
l domain/ 
supernum
erary	  
Arg321Pro 
(286) <30  Leigh syndrome 
Affected assembly due to 
misfolding of NDUFA9 
subunit; one of the amino 
acids coordinating NADPH 
 
[52]	  
Arg360Cys 
(325) <61 
accumulation of 
several low and high 
molecular weight 
complex I assembly 
intermediates 
Miscellaneous: dystonia, 
dysarthria, Leigh 
syndrome, raised blood 
lactate 
Affected assembly due to 
impaired interaction of 
NDUFA9, NDUFA6 and 
ND3 subunits; located on a 
loop making contacts with 
NDUFA6 and ND3 subunits 
 
[136] 
NDUFA
1	  
MWFE	  
Membran
e domain/ 
supernum
erary	  
Gly8Arg (8) <20  
decreased levels of 
intact complex I with 
no accumulation of 
lower molecular 
weight 
subcomplexes. 
 
Encephalomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFA1 and ND1 subunits 
[137]	  
Gly32Arg 
(32) <50  Encephalomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFA1, NDUFA8, 
NDUFA13 and ND1 
subunits; located at a loop 
interacting with NDUFA8, 
ND1 and NDUFA13 
[63,138]	  
	  
Arg37Ser 
(37) <70 
decreased levels of 
intact complex I with 
no accumulation of 
lower molecular 
weight 
subcomplexes 
Encephalomyopathy 
Affected assembly due to 
impaired interaction of 
NDUFA1, NDUFA8, 
NDUFA13 and ND1 
subunits; located at a loop 
interacting with NDUFA8, 
ND1 and NDUFA13 
[137]	  
NDUFA
8	  
PGIV	  
Membran
e domain/ 
supernum
erary 
aGlu109Lys 
(108) N/A  
Miscellaneous: neonatal 
hypotonia, dysmorphic 
features, epilepsy and signs 
of brainstem involvement, 
lactic acidosis 
Change is associated with 
instability of the mutant 
transcript 
[54]	  
NDUFA
10	  
42kDa	  
Membran
e domain/ 
supernum
erary	  
Gly99Glu 
(64) <25  Encephalomyopathy 
Affected assembly due to 
misfolding of NDUFA10 
subunit, located at the 
interface with the ND2 and 
NDUFC1 (KFYI) subunits 
[63]	  
Gln142Arg 
(107) <29  Leigh syndrome 
Affected assembly due to 
misfolding of NDUFA10 
subunit 
[139]	  
NDUFA
13	  
B16.6	  
Membran
e domain/ 
supernum
erary	  
Lys5Asn 
(4)d N/A  Tumours of thyroid 
Affected assembly due to 
impaired interaction of 
NDUFA13 and NDUFA7 
subunits, located at a start of 
the N-terminal coil which 
binds to the NDUFA7 
subunit 
[140]	  
NDUFB
9	  
B22	  
Membran
e domain/ 
supernum
erary	  
Leu64Pro 
(63) 
 
>50  
Miscellaneous: raised 
blood lactate, muscular 
hypotonia 
 
Affected assembly due to 
impaired interaction of 
NDUFB9 and NDUFAB1 
subunits, located at PNS co-
factor binding pocket 
 
[63]	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transfer, negatively charged quinone (or charged residues nearby) initiate a cascade of 
conformational changes, indicated by a series of double red arrows (Figure I). Shifts of 
helices near the cluster N2 may help initiate these changes [141]. They originate around 
the so-called E-channel, a proton translocation channel formed near the Q-site by 
subunits ND1, ND3, ND6 and ND4L [15]. Additionally, three antiporter-like subunits 
(ND2, ND4 and ND5) each contain a single proton channel formed by two connected 
half-channels, with key Lys/Glu residues sitting on breaks in TM helices (blue/red 
circles) [15,21]. Black arrows in Figure I indicate possible proton transfer pathways. 
Conformational changes propagate from the Q site/E-channel to the antiporter-like 
subunits via the central flexible hydrophilic axis, causing changes both in pKa and in 
access to proton networks of key Lys/Glu residues. ND5 helix HL and traverse helices 
from four supernumerary subunits on the IMS side (NDUFB10, NDUFB5, NDUFS5 
and NDUFA8) may serve as stators. Subunits NDUFA10 and NDUFA5 provide 
additional, possibly regulatory, contact between the peripheral and membrane arms. 
Green and red arrows around the tip of PA indicate the proposed shift of the arm in 
transition between different states (A/D or catalytic). This movement is correlated with 
re-organisation (green/red arrows) of the β1-β2NDUFS2(49kDa) and α1-α2ND3 loops pictured 
as black lines. The NADPH-containing NDUFA9 (39kDa) subunit [53] and Zn-
containing NDUFS6 (13kDa) subunit [51] are essential for activity and may serve as 
redox sensors. Both NDUFAB1 (SDAP) subunits interact with their LYR partners 
(NDUFA6 and NDUFB9) via flipped-out phosphopantetheine (black line). The net 
result of one conformational cycle, driven by NADH:ubiquinone oxidoreduction, is the 
translocation of four protons across the membrane. 
 
Figure I. Graphical overview of the putative complex I mechanism and associated 
conformational changes. Core and putatively regulatory or stabilizing supernumerary 
subunits, discussed in Box 1, are shown.  
 
 
Figure 1. Architecture of respiratory complex I.  
Complex I core subunits, conserved from bacteria, are shown in different colours for 
each of the modules: N-module (NADH-oxidizing), Q-module (connecting) and the 
proximal (Pp) and distal (Pd) proton-pumping modules. Approximate position of the 
membrane is indicated, and the Fe-S clusters and FMN in the matrix arm are shown as 
spheres. All supernumerary subunits are shown in transparent grey. Illustrated using 
atomic structure of the mammalian (ovine) complex I (PDB: 5LNK) [21]. 
 
Figure 2. Comparison of recently published structures of complex I. Complex I 
pictured as a cartoon (panels A, C and E) or ribbon (panels B, D and F) and aligned by 
ND1-ND4 subunits (Box 1). Ovine complex I (PDB: 5LNK) is shown in blue, porcine 
(PDB: 5GUP) in red and bovine (PDB: 5LC5) in green. Arrows indicate the direction of 
movement and rotation of the PA and MD. Dashed lines indicate cross-sections shown 
in corresponding panels. (A) Side view of complex I. (B) Approximately perpendicular 
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to the rotation axis cross-section of complex I PA. (C) ‘Back’ view of complex I. (D) 
Cross section of complex I MD approximately in the middle of the inner mitochondrial 
membrane. (E) Matrix side view of complex I. (F) Ubiquinone (Q) binding site of 
complex I with the crucial β1-β2NDUFS2(49kDa) loop and Q molecule modelled based on 
the T. thermophilus structure (PDB: 4HEA). MD, membrane domain; PA, peripheral 
arm. 
 
Figure 3. Overview of complex I deficiency-causing mutations. Complex I is 
depicted as a transparent cartoon with core matrix arm subunits coloured in orange, core 
membrane arm subunits in blue, supernumerary subunits bearing mutations in pink and 
mutations-free in green. Amino acids mutated in patients suffering from complex I 
dysfunction are presented as spheres. Leigh syndrome in red, LHON in purple, broad-
spectrum phenotype in black and other diseases in yellow. LHON, Leber’s hereditary 
optic neuropathy. 
 
 
Figure 4. Examples of disease causing-mutations in human complex I. Proteins are 
pictured as a cartoon with each subunit in a different color, natural variants of amino 
acids as light pink sticks and disease-causing substitutions as black sticks. Co-factors 
are labelled in bold. (A) NDUFS1 (75kDa) subunit. (B) NDUFV1 (51kDa) subunit. (C) 
NDUFS2 (49kDa) subunit. (D) NDUFS8 (TYKY) subunit. (E) ND1 subunit. (F) ND6 
subunit. (G) NDUFS6 (13kDa) subunit. (H) NDUFB9 (B22) subunit in blue and 
NDUFAB1-β (SDAP-β) subunit in pink. (I) ND5 subunit. (J) NDUFA9 (39kDa) 
subunit. (K) NDUFA1 (MWFE) subunit. (L) NDUFA10 (42kDa) subunit. 
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